# RHA®4 for Midface Volume Deficiency

> **NCT05133739** · — · COMPLETED · sponsor: **Teoxane SA** · enrollment: 201 (actual)

## Conditions studied

- Cheek Augmentation
- Correction of Age-related Midface Contour Deficiencies

## Interventions

- **DEVICE:** injection of RHA®4 in Midface
- **DEVICE:** injection of Comparator Product in Midface

## Key facts

- **NCT ID:** NCT05133739
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-29
- **Primary completion:** 2023-01-17
- **Final completion:** 2024-01-29
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133739, "RHA®4 for Midface Volume Deficiency". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT05133739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*